Vascular Disease and Thrombosis

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy Researchers at Heart Tirofiban for Reduction of TEAR: A Phase 2, Randomized, Open-Label, Blinded End Point, Controlled Trial Activation of HIF2 in Cardiac Vasculature Leads to Arterial Remodeling, Dilation, Thrombosis, and Inflammation, Recapitulating Cardiac Involvement in Kawasaki Disease Thrombus and Aortic Wall 18F-FDG Positron Emission Tomography Uptake in Abdominal Aortic Aneurysms Seasonality of Selected Cardiovascular Disorders in Austria: A Retrospective Observational Study Between 2009 and 2023 Classification and Management of Ischemic Stroke in Patients with Active Cancer 2026 Heart Disease and Stroke Statistics Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Healthcare Getting to the Heart of Stroke™: Life after Stroke – Challenges and Advances in Rehabilitation